{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": null, "type_of_material": "News", "word_count": "206", "lead_paragraph": "The British drug maker plans to acquire treatments at various stages of research in a deal with Bristol-Myers Squibb of New York that could be worth $1.46 billion.", "pub_date": "2015-12-19T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "GlaxoSmithKline to Buy Raft of H.I.V. Drugs in Development"}, "snippet": "The British drug maker plans to acquire treatments at various stages of research in a deal with Bristol-Myers Squibb of New York that could be worth $1.46 billion.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/12/19/business/dealbook/gsk-bristol-myers-hiv.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Acquired Immune Deficiency Syndrome", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Bristol Myers Squibb Company", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "London (England)", "name": "glocations"}, {"rank": "8", "is_major": "N", "value": "Japan", "name": "glocations"}], "blog": [], "_id": "5673f32038f0d85bed90f5e1", "source": "The New York Times"}